Clinical Trial Update: KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study [EARLY_Phase 1]

View source ↗

Summary

An early exploratory Phase 1 study evaluating KSD-201 for advanced clear cell renal cell carcinoma; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• KSD-201

Snippet

Sponsor: Kousai Bio Co., Ltd. | Conditions: Clear Cell Renal Cell Carcinoma (ccRCC) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING